Most uncomplicated yeast infections clear within a few days using either an over-the-counter antifungal cream or a single dose of oral fluconazole. Both approaches work well for the garden-variety infection caused by Candida albicans, and clinical trials consistently show cure rates above 80 percent with either route. The picture gets more complicated when infections recur, when the species involved is resistant to standard drugs, or when pregnancy limits your options. Understanding which treatment fits your situation is the difference between a quick fix and months of frustration.
Make Sure It Is Actually a Yeast Infection
Before reaching for any treatment, it is worth pausing on diagnosis. Many people assume they can tell a yeast infection by its symptoms alone, but the research says otherwise. In one study of military women using a self-diagnostic guide, self-diagnosis accuracy for yeast infections was only about 69 percent, and roughly 8 percent of women who thought they had one did not, meaning they would have medicated unnecessarily.1PubMed Central. Accuracy of Vaginal Symptom Self-Diagnosis Algorithms for Deployed Military Women A separate clinical study gave women a structured decision-making kit and found somewhat better results, with sensitivity for candida vaginitis reaching 84 percent, but that still means roughly one in six cases was missed.2PubMed. A clinical test of women’s self-diagnosis of genitourinary infections Bacterial vaginosis, trichomoniasis, and even contact irritation can all mimic yeast infection symptoms. If you are treating what you think is a yeast infection and it is not clearing up, a clinician visit or molecular test can sort out what is really going on.3PubMed Central. Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis
Over-the-Counter Topical Antifungals
The most accessible first-line treatment is a topical azole cream or suppository, available without a prescription in most countries. Clotrimazole and miconazole are the two you will see most often on pharmacy shelves, and head-to-head trials show they perform nearly identically. In one double-blind study comparing seven-day courses of clotrimazole 1% cream and miconazole 2% cream, negative vaginal cultures at one week were found in about 85 percent of patients in both groups, and at four weeks the rates were still comparable, around 75 percent for each.4PubMed. A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use Shorter courses (one-day or three-day formulations) are also sold over the counter and work for many people, though the seven-day course tends to be recommended for anyone whose symptoms are more severe or who has had trouble with shorter regimens in the past.
The main drawback of topical treatment is the mess and inconvenience. Creams can leak, suppositories need to be inserted at bedtime, and some people find the process irritating in more ways than one. But for someone with a first or infrequent yeast infection, an OTC cream is usually the simplest path forward.
Oral Fluconazole
If you would rather skip the creams, a single 150-milligram dose of oral fluconazole is the standard prescription alternative. It works systemically, reaching vaginal tissue through the bloodstream, and most people feel relief within a day or two. A trial comparing single-dose oral fluconazole to single-dose topical miconazole found clinical cure or improvement in all fluconazole-treated patients in the short term and 95 percent at long-term follow-up, with the two treatments showing no significant difference overall.5PubMed. Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis
Another trial found that at a follow-up visit, about 85 percent of fluconazole-treated patients and 83 percent of clotrimazole-treated patients were clinically cured, but fluconazole showed a clear advantage in preventing relapse at a later check: only one patient in the fluconazole group still had clinical signs of infection compared with 17 in the clotrimazole group.6PubMed. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis That difference is striking, though it is worth noting that individual trials can exaggerate effects, and other comparisons show more modest gaps. In practice, either route works. The choice often comes down to personal preference and whether you have access to a prescription.
When Infections Keep Coming Back
Recurrent vulvovaginal candidiasis, defined as four or more episodes in a year, affects a meaningful minority of women and is genuinely difficult to manage. A single course of treatment knocks down the current episode, but it does nothing to prevent the next one. This is where maintenance therapy comes in.
The landmark approach is weekly oral fluconazole for six months after the acute infection is cleared. A large trial published in the New England Journal of Medicine found that 90 percent of women on weekly fluconazole remained disease-free at six months, compared with about 36 percent on placebo. Even at a year (six months after stopping the maintenance dose), roughly 43 percent of the fluconazole group was still disease-free versus about 22 percent of the placebo group. The median time to recurrence was more than ten months with fluconazole and four months with placebo.7PubMed. Maintenance Fluconazole Therapy for Recurrent Vulvovaginal Candidiasis The trade-off is clear: maintenance therapy works well while you are on it, but a good number of people relapse once they stop. Some clinicians extend the regimen longer than six months for patients who relapse quickly.
Non-Albicans Species and Drug Resistance
Not all yeast infections are created equal. While Candida albicans is the most common culprit, non-albicans species account for a sizable share. One study of 87 Candida isolates from women with vulvovaginal candidiasis found that about 41 percent were non-albicans species.8PubMed Central. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern Among those, C. glabrata is the most clinically troublesome because it is innately resistant to the azole drugs that work so well against C. albicans.9PubMed Central. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans
If you have been cycling through fluconazole and OTC creams without lasting improvement, a non-albicans species may be the reason. Getting a culture or PCR test is the only reliable way to know.10PubMed. The Role of PCR in the Diagnosis of Candida Vulvovaginitis-a New Gold Standard? Treatment for azole-resistant infections often requires different drugs entirely. One case report described a woman with two years of recurrent C. glabrata symptoms who finally improved on compounded intravaginal amphotericin B and flucytosine alongside lifestyle changes.11The Journal for Nurse Practitioners. The Treatment Challenge of Vulvovaginal Candida glabrata: A Case Report These are not first-line drugs and can be harder to obtain, but they represent a real option when standard treatments fail.
Newer Prescription Options
Two recently approved drugs are expanding the toolkit. Ibrexafungerp is the first oral antifungal in a new drug class, the glucan synthase inhibitors, to be approved for acute vulvovaginal candidiasis. It works differently from azoles and is active against many azole-resistant Candida species. Oteseconazole, on the other hand, is a long-acting tetrazole approved specifically for preventing recurrent vulvovaginal candidiasis. It binds more selectively to the fungal target enzyme than older azoles, which may mean fewer side effects and drug interactions.12PubMed Central. The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective Both are prescription-only and relatively new, so they tend to be reserved for cases where older drugs have not done the job or where recurrence is a problem. If your current treatment plan is not working, these are worth discussing with a clinician.
Boric Acid Suppositories
Intravaginal boric acid capsules occupy an interesting niche. They are not FDA-approved for yeast infections, but they have been used for decades, particularly for azole-resistant or non-albicans infections. A review of the clinical evidence found that mycologic cure rates across case series ranged from 40 to 100 percent, with vaginal burning being the most commonly reported side effect in fewer than 10 percent of cases.13PubMed. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence A retrospective chart review of clinicians prescribing maintenance boric acid found an average treatment duration of 13 months, with high patient satisfaction and few adverse events.14PubMed Central. Clinicians’ Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis
The important caveat is that the evidence base for boric acid is weaker than for standard antifungals. Most data come from case series rather than randomized controlled trials. Boric acid is also toxic if swallowed, so it must be used only intravaginally and kept away from children. It should not be used during pregnancy. For someone dealing with a stubborn, azole-resistant infection, boric acid is a reasonable option to discuss with a provider, but it is not a substitute for first-line therapy in a straightforward case.
Probiotics
The idea that probiotics can fight yeast infections has intuitive appeal. Lactobacillus species are a dominant part of a healthy vaginal microbiome, and lab studies show they can inhibit Candida growth through competition for space and production of antimicrobial compounds.15Journal of Applied Microbiology. Action mechanisms of probiotics on Candida spp. and candidiasis prevention: an update But what works in a petri dish does not always work in a person.
The clinical evidence is mixed. A meta-analysis looking at probiotics alone versus placebo found no difference in culture-positive rates, meaning probiotics on their own did not reliably clear an active infection. However, the same analysis found that probiotics did reduce recurrence rates.16PubMed Central. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis A more recent systematic review confirmed this pattern: combining probiotics with antifungal treatment improved short-term cure rates and reduced six-month recurrence, but probiotics alone did not outperform antifungal drugs for clearing an active infection, and any benefits tended to fade over the long term.17PubMed. Probiotics for the treatment of vulvovaginal candidiasis in nonpregnant women: a systematic review and meta-analysis of randomized controlled trials
The practical takeaway: probiotics are not a replacement for antifungal medication if you have an active infection. They may be a useful add-on for preventing recurrence, but the certainty of the evidence is still low. If you want to try them, use them alongside your prescribed treatment, not instead of it.
Home Remedies That Lack Good Evidence
Tea tree oil and garlic are among the most commonly mentioned home remedies, and both do show antifungal activity in lab studies. But a systematic review noted that these in vitro results have not been followed by adequate human trials, which means there is no reliable way to know whether they work in real life, at what concentration, or whether they are safe when applied vaginally.18Obstetrical & Gynecological Survey. Common Complementary and Alternative Therapies for Yeast Vaginitis and Bacterial Vaginosis: A Systematic Review Tea tree oil has slightly more clinical testing than most herbal remedies, with a handful of randomized trials showing some positive outcomes, though the quality of those trials is variable.19PubMed. Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials An overview of alternative therapies cautioned that natural products like garlic, tea tree oil, and even vinegar can cause side effects of their own and have not been tested in well-designed clinical studies.20PubMed. Alternative and complementary therapies for vulvovaginal candidiasis
Yogurt applied vaginally is another folk remedy that surfaces frequently. While the Lactobacillus in yogurt is related to the probiotic strains discussed above, food-grade yogurt is not formulated for vaginal use, and there is no convincing trial evidence that it works. Given how cheap and effective OTC antifungals are, experimenting with unproven remedies when a straightforward option exists does not make much sense for most people.
Treatment During Pregnancy
Pregnancy increases the risk of yeast infections because of rising estrogen levels, which promote Candida colonization.21PubMed Central. Cellular and molecular biology of Candida albicans estrogen response Treatment options narrow, though. Topical azole antifungals (creams and suppositories) are considered the recommended treatment during pregnancy and are generally used for at least seven days, since shorter courses may be less effective in this population.22PubMed Central. Vaginal yeast infections during pregnancy
Oral fluconazole, the convenient one-pill option for non-pregnant patients, is not recommended during pregnancy. There is evidence that fluconazole at higher doses may cause birth defects, and while the risk at the standard 150-milligram dose appears low, the consensus is to avoid systemic azole therapy altogether when topical alternatives are available.23PubMed. Use of antifungal drugs in pregnancy: a focus on safety 24Clinical Infectious Diseases. Antifungal Therapy During Pregnancy If you are pregnant and dealing with a yeast infection, stick with topical treatment and talk to your provider before taking anything by mouth.
Diabetes and Blood Sugar Control
Poorly controlled diabetes is one of the strongest predisposing factors for yeast infections. High blood glucose raises vaginal glycogen levels, which lowers vaginal pH and creates an environment where Candida thrives. Research has found that women with vulvovaginal candidiasis tend to have higher average blood sugar levels than those without, and poor glycemic control increases the risk of both initial infection and recurrence.25PubMed Central. The Interplay Between Sugar and Yeast Infections: Do Diabetics Have a Greater Predisposition to Develop Oral and Vulvovaginal Candidiasis? 26PubMed. Genital mycotic infections in patients with diabetes
For someone with diabetes who keeps getting yeast infections, the antifungal is treating the symptom, but blood sugar management is treating the cause. Getting glucose under better control can meaningfully reduce how often infections come back. This does not mean sugar causes yeast infections in otherwise healthy people, but if you have diabetes or prediabetes and are dealing with recurrent episodes, that connection is worth taking seriously.
Antibiotics as a Trigger
Antibiotics are the single most common and predictable trigger for a yeast infection.27PubMed. Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure The mechanism is not fully understood, but the likely explanation is that antibiotics wipe out protective vaginal bacteria, allowing Candida to grow unchecked. One large post-marketing surveillance study found that women taking antibiotics had a significantly elevated risk of vaginal candidiasis compared with women taking antidepressants as a control, with the highest risk in the second week of antibiotic use.28PubMed. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England Another study pegged the overall relative risk at about 2.3, with cephalosporins carrying the highest attributable risk among antibiotic classes.29QJM: An International Journal of Medicine. The risks of symptomatic vaginal candidiasis after oral antibiotic therapy
If you know from experience that antibiotics give you a yeast infection, it is reasonable to ask your clinician for a fluconazole prescription to have on hand. Some providers will proactively prescribe one alongside certain antibiotic courses, though this is a clinical judgment call rather than a universal guideline.
Does Your Partner Need Treatment Too?
This is one of the most persistent questions, and the answer from the research is surprisingly clear: no. Multiple randomized controlled trials have tested whether treating male sexual partners reduces cure rates or recurrence in women with vaginal candidiasis, and the results consistently show no benefit. One double-blind study found that cure and recurrence rates were identical whether or not the male partner received simultaneous antifungal treatment.30PubMed. Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study A second trial came to the same conclusion: treating partners with ketoconazole did not influence cure or recurrence rates.31PubMed. The value of treating the male partner in vaginal candidiasis Even in women with recurrent infections, a trial following patients for a full year found no difference in relapse whether or not the male partner was treated.32Sexually Transmitted Infections. The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole
Yeast infections are not typically considered sexually transmitted. Candida is a normal part of the body’s flora, and the infection arises from an overgrowth of organisms already present rather than from transmission between partners. Routine partner treatment is not recommended.
Lifestyle Adjustments and Prevention
A survey of women with recurrent vaginal candidiasis asked what lifestyle changes they found most helpful. The top three were reducing sugar intake, keeping the perineal area dry, and stopping oral contraceptive pills.33PubMed. Self-elimination of risk factors for recurrent vaginal candidosis These are self-reported and not from a controlled trial, so they should be taken as suggestive rather than proven. Still, they align with what we know about the biology: sugar feeds yeast growth, moisture creates a hospitable environment, and hormonal shifts from contraceptive pills can alter vaginal conditions.
Practical steps that are low-cost and low-risk include wearing breathable cotton underwear, changing out of wet swimsuits or workout clothes promptly, and avoiding douching or heavily fragranced products in the vaginal area. None of these will cure an active infection, but they remove conditions that make infections more likely. If you are on an oral contraceptive and dealing with frequent yeast infections, switching to a non-hormonal method is a conversation worth having with your provider, though the decision involves weighing many other factors beyond yeast infection risk alone.